ArticleScientific reports2026
Impact of vitamin D deficiency on 6-month culture conversion in nontuberculous mycobacterial pulmonary disease.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
Abstract
Vitamin D modulates antimycobacterial immunity, and its deficiency has been implicated in susceptibility to nontuberculous mycobacterial pulmonary disease (NTM-PD). However, whether baseline vitamin D status influences treatment outcomes remains unclear. We analyzed 485 patients with available baseline serum 25-hydroxyvitamin D [25(OH)D] levels and 6-month culture data from a prospective multicenter cohort (NTM-KOREA) enrolled between April 2022 and August 2025. Vitamin D deficiency was defined as 25(OH)D < 20 ng/mL. The mean age was 64.0 years, 73.2% were female, and 99 (20.4%) had vitamin D deficiency. The overall 6-month culture conversion rate was 44.9%, with no significant difference between deficient and non-deficient groups (42.4% vs. 45.6%; p = 0.651). In multivariable logistic regression, vitamin D deficiency was not associated with culture conversion (adjusted odds ratio [aOR] 1.091; 95% CI 0.662-1.797; p = 0.733), whereas guideline-based treatment showed a strong positive association (aOR 3.781; 95% CI 1.825-7.832; p < 0.001). Multivariable Cox regression confirmed no association between vitamin D deficiency and time to conversion (adjusted hazard ratio 1.031; 95% CI 0.721-1.475; p = 0.868). Baseline vitamin D deficiency was not independently associated with 6-month culture conversion or time to conversion in treated NTM-PD patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.